The health authorities reported 1,274 new cases, taking the caseload to 388,569. Currently, there are 78,937 active cases in the country, said the Directorate General of Health Services (DGHS).
Bangladesh reported its first cases on March 8 and the first death on March 18. The cases reached the 300,000-mark on Aug 26 while the death toll exceeded 5,000 on Sept 22.
The fatality rate is 1.46 percent.
So far, 21,63,568 samples have been tested — 11,866 in the last 24 hours — and 17.96 percent of them have turned out to be positive.
Bangladesh’s recovery rate is steadily increasing with 1,674 new recoveries. So far, 303,972 patients have recovered with a recovery rate of 78.23 percent, the health authorities said.
Of the total victims, 4,357 are men and 1,303 are women. Among the latest victims, 13 are above 50 years of age and one other is aged between 31 and 40 years.
So far, 2,895 people have died in Dhaka division, 1,134 in Chattogram, 362 in Rajshahi, 457 in Khulna, 196 in Barishal, 240 in Sylhet, 257 in Rangpur and 119 in Mymensingh.
Currently, 12,265 people are in isolation and 39,776 in quarantine.
The global death toll from coronavirus hit 1,108,607 as of Sunday, according to the latest tally from Johns Hopkins University (JHU).
Besides, the total caseload from Covid-19 surpassed 39.5 million with 27,148,927 recoveries, JHU data show.
The US continues to be the worst-affected country with 8,102,142 cases and 219,157 fatalities. India’s total caseload reached 7,432,680 while the South Asian country has recorded 112,998 deaths as of Sunday morning.
Indian Prime Minister Narendra Modi on Saturday said there are requests from Bangladesh, Myanmar, Qatar and Bhutan for clinical trials of Covid-19 vaccine.
Indian scientists and research teams are collaborating and strengthening research capacities in neighbouring countries.
Three vaccine candidates are at the advanced stages of development in India and two of them are in Phase II and one in Phase-III stages.
In an effort to help the global community, Modi directed that they should not limit their efforts to their immediate neighbourhood but also reach out to the entire world in providing vaccines, medicines and IT platforms for the vaccine delivery system.